Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological markers in multiple sclerosis: tackling the missing elements.

L Rinaldi1, P Gallo

  • 1Research & Innovation R&I Company, Via Svizzera 16, I-35127 Padua, Italy. rinaldi@researchinnovation.com

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|January 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Simultaneous administration of human acidic and recombinant less acidic follicle-stimulating hormone for ovarian stimulation improves oocyte and embryo quality, and clinical outcome in patients with repeated IVF failures.

European review for medical and pharmacological sciences·2026
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Exposure to selected pathogens in wild mammals from a rescue and rehabilitation center in southern Italy.

One health (Amsterdam, Netherlands)·2025
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same journal

Primary Sjogren syndrome with suspected central nervous system inflammatory involvement.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Efficacy of repetitive transcranial magnetic stimulation for post-stroke spasticity: a meta-analysis of randomized controlled trials.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Diverging trends in motor neuron disease burden in China: an ageing-driven increase despite declining age-standardised rates - a GBD 2021 analysis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: a systematic review and meta-analysis with subgroup evaluation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Ultrashort echo time magnetic resonance angiography for embolized intracranial aneurysm with coil protrusion into the small parent vessel in the posterior circulation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Mixing apples and antibodies: when the Cochrane average obscures the evidence in Alzheimer's disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
See all related articles

Researchers are seeking reliable immune markers for multiple sclerosis (MS) to understand disease heterogeneity and guide treatment. While ideal biomarkers remain elusive, recent discoveries offer new hope for personalized therapies.

Area of Science:

  • Immunology
  • Neurology
  • Biomarker Discovery

Background:

  • Multiple sclerosis (MS) is a complex neurological disorder characterized by inflammation, demyelination, and axonal damage.
  • Disease heterogeneity in MS leads to variable clinical presentations, prognoses, and treatment responses.
  • Identifying specific biomarkers is crucial for accurate diagnosis, prognosis, and development of targeted therapies.

Purpose of the Study:

  • To review recent advancements in identifying immune markers for multiple sclerosis (MS).
  • To discuss the potential of these markers in predicting disease course and therapeutic response.
  • To highlight the ongoing search for biomarkers to enable process-specific therapies in MS.

Main Methods:

  • Literature review of recent studies on immune markers in multiple sclerosis.

Related Experiment Videos

  • Analysis of current research on biomarker candidates for MS.
  • Discussion of the role of immune system dysregulation in MS pathogenesis.

    • Main Results:

    • No definitive "gold standard" immune biomarkers for MS have been identified to date.
    • Recent studies have revealed promising new candidate immune markers.
    • These candidates show potential for predicting disease heterogeneity and treatment outcomes.

    Conclusions:

    • The search for reliable immune biomarkers in MS is ongoing and critical.
    • Emerging immune markers offer new avenues for understanding MS and developing targeted treatments.
    • Continued research into immune markers is essential for advancing MS care and therapy development.